FIELD: bioengineering.
SUBSTANCE: invention relates to creation of low-toxic cation dendrimer peptide with structural formula (Arg)8(Lys)4(Lys)2LysAlaCys-NH2 (Fig. 1). The said dendrimer peptide is used as the mean for intracellular delivery of nucleic acids to cells of mammals. At ratio of number of positive charges to number of negative phosphate groups of the nucleic acids from 24 to 96 the dendrimer peptide can effectively penetrate in different types of cells of the mammals and completely interact with the plasmid DNA. At LD50 for 0.8-1.5 mg/ml the mean for intracellular delivery of nucleic acids to cells of mammals is low toxic.
EFFECT: higher efficiency of the mean.
2 cl, 12 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2020 |
|
RU2771605C2 |
LABELLED DENDRIMER PEPTIDES | 2016 |
|
RU2611399C1 |
COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
COMPOSITION INHIBITING EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-13 GENES FOR THERAPY OF ALLERGIC RHINITIS | 2018 |
|
RU2710895C1 |
VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
USE OF DENDRIMER NANOTECHNOLOGY FOR DELIVERY OF BIOMOLECULES INTO PLANT CELLS | 2010 |
|
RU2571928C2 |
HISTONES AND BIODEGRADABLE LIPIDES AS MEANS FOR NUCLEIC ACIDS DELIVERY TO EUKARYOTIC CELLS | 2015 |
|
RU2637371C2 |
BIODEGRADABLE CATIONIC POLYMERS | 2005 |
|
RU2440380C2 |
AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE | 2020 |
|
RU2733361C1 |
Authors
Dates
2016-01-20—Published
2014-10-31—Filed